Journal Article 2023 Cancer Immunology, ImmunotherapyThe landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigatingYize Mao†, Hui Xie†, Min-Yi LV†, Qiuxia Yang, Zeyu Shuang, Feng GAO, Shengping Li*, Lina Zhu*, Wei Wang*